by Site Dev | Oct 22, 2021 | Breast, Clinical Trials
Breast CancerClinical Trials Contact Us 1) Up to 3 lines of post-adjuvant or neoadjuvant therapy for TNBC/AYALA: AL-TNBC-01: A Phase 2, Multicenter, Open-label study of AL101 Monotherapy in Patients with Notch Activated Recurrent or Metastatic Triple Negative Breast...
